Related Experiment Video
Updated: Aug 21, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
Magnesium, insulin resistance and body composition in healthy postmenopausal women
Maria J Laires1, Helena Moreira, Cristina P Monteiro
1Laboratório de Bioquímica, Faculdade de Motricidade Humana, Estrada de Costa 1495-688 Cruz Quebrada, Portugal. mjlaires@fmh.utl.pt
Objective:
This study was conducted to determine the association between magnesium (Mg), body composition and insulin resistance in 136 sedentary postmenopausal women, 50 to 77 years of age.
Methods:
Diabetics, hypertensives and women on hormonal replacement therapy were excluded and the remaining 74 were divided according to BMI> or =25 (obese: OG) and BMI<25 kg/m(2) (non-obese: NOG). Nutritional data disclosed that intakes were high for protein and saturated fat, low for carbohydrates, polyunsaturated fat and Mg and normal for the other nutrients, according to recommended dietary allowances (RDA). Mg values in red blood cells (RBC-Mg) and plasma (P-Mg), were determined, as were fasting glucose, and insulin levels, Homeostasis Model Assessment (HOMA), body mass index (BMI), body fat percent (BF %), abdominal fat (AF) and free fat mass (FFM).
Results:
RBC-Mg values were low in both groups when compared with normal values. There were significant differences in body composition parameters, HOMA and insulin levels, with higher basal insulin levels in OG. RBC-Mg was directly correlated with insulin, HOMA and FFM in both groups, according to Pearson correlations. HOMA in OG was also directly correlated with BMI, FFM and AF. In NOG, HOMA was only correlated with FFM. The low RBC-Mg levels observed were probably due to low Mg intake and to deregulation of factors that control Mg homeostasis during menopause.
Conclusions:
Both Mg deficit and obesity may independently lead to a higher risk for insulin resistance and cardiovascular disease.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Oral Hypoglycemic Agents: Biguanides and Glitazones
Type II Diabetes I: Introduction
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...